(Q53497293)

14 May 2018

reason for preferred rank

title

Kl 67 immunostaining in melanocytic skin tumors. Correlation with histologic parameters (English)

1 reference

https://api.crossref.org/works/10.1111/J.1600-0560.1991.TB01234.X

7 November 2022

Ki 67 immunostaining in melanocytic skin tumors. Correlation with histologic parameters (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1719049

7 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-0560.1991.TB01234.X

7 November 2022

author name string

H. P. Soyer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1719049

7 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1719049

7 November 2022

publication date

1 August 1991

1 reference

14 May 2018

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0560.1991.tb01234.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-0560.1991.TB01234.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0560.1991.tb01234.x/fullpdf

7 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-0560.1991.TB01234.X

Journal of Cutaneous Pathology

7 November 2022

published in

1 reference

14 May 2018

volume

18

1 reference

14 May 2018

issue

4

1 reference

14 May 2018

page(s)

264-272

1 reference

14 May 2018

Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.1991.TB01234.X

Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.1991.TB01234.X

Cell cycle-dependent reactivity with the monoclonal antibody Ki-67 during myeloid cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.1991.TB01234.X

Ki67 immunostaining in primary breast cancer: pathological and clinical associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.1991.TB01234.X

Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.1991.TB01234.X

Nuclear size and shape parameters correlate with proliferative activity in cutaneous melanocytic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.1991.TB01234.X

Identity of the proliferating cell nuclear antigen and cyclin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.1991.TB01234.X

Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.1991.TB01234.X

Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.1991.TB01234.X

Prognostic relevance of tumour-cell growth fraction in malignant non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.1991.TB01234.X

The Ki-67 antigen in primary human melanomas--its relationship to mitotic rate and tumor thickness and its stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.1991.TB01234.X

The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.1991.TB01234.X

The cell cycle associated change of the Ki-67 reactive nuclear antigen expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.1991.TB01234.X

Inhibition of nuclear DNA synthesis by an autoantibody to proliferating cell nuclear antigen/cyclin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.1991.TB01234.X

Vascular architecture of melanocytic skin tumors. A quantitative immunohistochemical study using automated image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.1991.TB01234.X

Image analysis applied to proliferating cells in malignant lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.1991.TB01234.X

Mitotic counts in follicular lymphomas

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1600-0560.1991.TB01234.X

Transferrin receptor expression in normal skin and in various cutaneous tumors

7 November 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1600-0560.1991.TB01234.X

Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin

7 November 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1600-0560.1991.TB01234.X

Comparative analysis of [3H]-thymidine labelling index and monoclonal antibody Ki-67 in non-Hodgkin's lymphomas

7 November 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1600-0560.1991.TB01234.X

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

7 November 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1600-0560.1991.TB01234.X

Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.

7 November 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1600-0560.1991.TB01234.X

Assessment of tumor cell kinetics by immunohistochemistry in carcinoma of breast

7 November 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1600-0560.1991.TB01234.X

Assessment of cell proliferation in colorectal carcinomas using the monoclonal antibody Ki-67. Correlation with pathohistologic criteria and influence of irradiation

7 November 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1600-0560.1991.TB01234.X

Proliferative activity of cutaneous melanocytic tumors defined by Ki-67 monoclonal antibody. A quantitative immunohistochemical study

7 November 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.1600-0560.1991.TB01234.X

Proliferation antigens in cutaneous melanocytic tumors--an immunohistochemical study comparing the transferrin receptor and the Ki 67 antigen

7 November 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1600-0560.1991.TB01234.X

Proliferative rates of non-Hodgkin's lymphomas as assessed by Ki-67 antibody

7 November 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1600-0560.1991.TB01234.X

The Influence of Staining Procedures on the Assessment of Cell Proliferation as Defined by the Monoclonal Antibody KI-67

7 November 2022

29

1 reference

https://api.crossref.org/works/10.1111/J.1600-0560.1991.TB01234.X

The correlation of growth fractions with histologic grading and lymph node status in human mammary carcinoma

7 November 2022

36

1 reference

https://api.crossref.org/works/10.1111/J.1600-0560.1991.TB01234.X

A comparison of nucleolar organizer region staining and Ki-67 immunostaining in non-Hodgkin's lymphoma

7 November 2022

37

1 reference

https://api.crossref.org/works/10.1111/J.1600-0560.1991.TB01234.X

Tumor Thickness, Level of Invasion and Node Dissection in Stage I Cutaneous Melanoma

7 November 2022

44

1 reference

https://api.crossref.org/works/10.1111/J.1600-0560.1991.TB01234.X

7 November 2022

Identifiers

1 reference

14 May 2018

1 reference

14 May 2018